Trial · NCT00438672
Corticosteroid Injection for Common Upper Extremity Problems
NCT00438672, Not applicable, Completed, Massachusetts General Hospital; results first posted 2012-05-28
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Corticosteroid Injection for Common Upper Extremity Problems. Trials, record NCT00438672. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT00438672
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Corticosteroid Injection for Common Upper Extremity Problems
- NCT number
- NCT00438672
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 64 participants, actual
- Lead sponsor
- Massachusetts General Hospital
- Conditions
- Lateral Elbow Pain
- Interventions
- Placebo Injection, Steroid (dexamethasone) Injection
- First posted
- 2007-02-22
- Last updated
- 2012-05-28
- Results first posted
- 2012-05-28
Source ClinicalTrials.gov
Registered outcomes2
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Disabilities of the Arm, Shoulder, and Hand (DASH) Questionnaire | 6 months | The DASH questionnaire measures arm-specific perceived disability. It contains 30 items and is scaled between zero and 100 with higher scores indicating worse upper-extremity function. |
| Primary | Visual Analog Scale for Pain | 6 months | Pain is measured on a 10 cm long line that starts at 0 on the left and ends with 10 on the right. A score of 0 represents no pain at all, and a score of 10 represents the worst pain ever. The individual score is measured using a measuring rod, measuring the distance from the left border in centimeters. |
Source ClinicalTrials.gov
Outcomes2
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Disabilities of the Arm, Shoulder, and Hand (DASH) Questionnaire | 6 months | units on a scale | MEAN | |
| PRIMARY | Visual Analog Scale for Pain | 6 months | units on a scale | MEAN |
Source ClinicalTrials.gov
Results by group4
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Disabilities of the Arm, Shoulder, and Hand (DASH) Questionnaire | Dexamethasone Cohort | 18 | Standard Deviation 20 | units on a scale | |
| Disabilities of the Arm, Shoulder, and Hand (DASH) Questionnaire | Placebo (Lidocaine Only) Cohort | 13 | Standard Deviation 19 | units on a scale | |
| Visual Analog Scale for Pain | Dexamethasone Cohort | 2.4 | Standard Deviation 2.9 | units on a scale | |
| Visual Analog Scale for Pain | Placebo (Lidocaine Only) Cohort | 1.7 | Standard Deviation 2.2 | units on a scale |
Source ClinicalTrials.gov
Participant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Dexamethasone Cohort | 31 | |
| Overall Study | STARTED | Placebo (Lidocaine Only) Cohort | 33 | |
| Overall Study | COMPLETED | Dexamethasone Cohort | 24 | |
| Overall Study | COMPLETED | Placebo (Lidocaine Only) Cohort | 24 | |
| Overall Study | NOT COMPLETED | Dexamethasone Cohort | 7 | |
| Overall Study | NOT COMPLETED | Placebo (Lidocaine Only) Cohort | 9 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Dexamethasone Cohort | ||
| Total, all-cause mortality | Placebo (Lidocaine Only) Cohort | ||
| Total, other adverse events | Dexamethasone Cohort | 0 | 31 |
| Total, other adverse events | Placebo (Lidocaine Only) Cohort | 0 | 33 |
| Total, serious adverse events | Dexamethasone Cohort | 0 | 31 |
| Total, serious adverse events | Placebo (Lidocaine Only) Cohort | 0 | 33 |
Source ClinicalTrials.gov
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons1
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison |
|---|
| Dexamethasone Cohort vs Placebo (Lidocaine Only) Cohort: serious adverse events |
Source Trial comparisons
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT00438672
GET https://conductscience.org/api/trials/v1/NCT00438672/registered